t. eoin west, MD, mph, fccp

T. Eion West, MD, MPH, FCCP

Associate Professor
Division of Pulmonary and Critical Care Medicine
Adjunct Associate Professor of Global Health

Contact Information

Harborview Medical Center
Campus Box 359640
606 Research & Training Bdg.
Seattle, WA 98104

Research Web Page
tewest@u.washington.edu
Academic Office: (206) 897-5271
Fax: (206) 897-5392

Return to Faculty Directory

Education and Training

BS in Geology and Geophysics, Yale University, New Haven, CT, 1995

MD, Medical College of Virginia/VCU, Richmond, VA, 1999 

Internship in Medicine, Boston University Medical Center, Boston, MA, 1999-2000

Residency in Medicine, Boston University Medical Center, Boston, MA, 2000-2002

Chief Medical Resident, Boston University Medical Center, Boston, and Boston VA Healthcare System, West Roxbury, MA, 2002-2003 

MPH, Harvard School of Public Health, Boston, MA, 2005

Fellowship in Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, 2003-2008 

ACLS certified

Research Interests

My research targets bacterial respiratory infections and sepsis, major global killers that disproportionately impact poor populations worldwide. I am particularly interested in using translational methods to understand the importance of specific components of innate immunity in these diseases. I am also involved in studies of the epidemiology and clinical management of bacterial infections and sepsis in low-resource regions. I participate in World Health Organization-sponsored efforts to develop and test guidelines for management of severely ill patients in low-resource settings. In related activities, I spearhead a multidisciplinary initiative at the University of Washington called INTERSECT, the International Respiratory and Severe Illness Center.

Representative Publications

Ortiz JR, Rudd KE, Clark DV, Jacob ST, West TE. Clinical research during a public health emergency: a systematic review of severe pandemic influenza management. Crit Care Med. 2013 May;41(5):1345-52.

West TE, Chantratita N, Chierakul W, Limmathurotsakul D, Wuthiekanun V, Myers ND, Emond MJ, Wurfel MM, Hawn TR, Peacock SJ, Skerrett SJ. Impaired Toll-like receptor 5 functionality is associated with survival in melioidosis. J Immunol. 2013 Apr 1:190(7):3373-9.

Jacob ST, Lim M, Banura P, Bhagwanjee S, Bion J, Cheng A, Cohen H, Farrar J, Gove S, Hopewell P, Moore CC, Roth C, West TE. Integrating sepsis management recommendations into clinical care guidelines for district hospitals in resource-limited settings: the necessity to augment new guidelines with future research. BMC Med. 2013 Apr 18;11:107.

Chantratita N, Tandhavanant S, Myers ND, Seal S, Arayawichanont A, Kliangsa-ad A, Hittle LE, Ernst RK, Emond MJ, Wurfel MM, Day NP, Peacock SJ, West TE. Survey of innate immune responses to Burkholderia pseudomallei in human blood identifies a central role for lipopolysaccharide. PLoS One. 2013 Nov 26;8(11):e81617.

Chantratita N, Tandhavanant S, Myers ND, Chierakul W, Robertson JD, Mahavanakul W, Singhasivanon P, Emond MJ, Peacock SJ, West TE. Screen of whole blood responses to flagellin identifies TLR5 variation associated with outcome in melioidosis. Genes Immun. 2014 Mar;15(2):63-71.

Myers ND, Chantratita N, Chierakul W, Limmathurotsakul D, Wuthiekanun V, Robertson JD, Berrington WR, Liggitt HD, Peacock SJ, Skerrett SJ, West TE. The role of NOD2 in murine and human melioidosis. J Immunol. 2014 Jan 1;192(1):300-7.

 

top of page